Boston, Medtronic Differ On Views For MRI Coverage In Pacemaker Patients
This article was originally published in The Gray Sheet
Boston Scientific says it agrees with CMS' decision to refrain from covering magnetic resonance imaging in cardiac pacemaker and implantable defibrillator patients for now
You may also be interested in...
Use of magnetic resonance imaging to assess heart valve disease in Medicare patients may be an easier proposition for physicians if a June 30 CMS coverage 1proposal is adopted
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.